ARv7 Represses Tumor-Suppressor Genes in Castration-Resistant Prostate Cancer. Published: March, 2019 Abstract:
Androgen deprivation therapy for prostate cancer (PCa) benefits patients with early disease, but becomes ineffective as PCa progresses to a castration-resistant state (CRPC). Initially CRPC remains dependent on androgen receptor (AR) signaling, of... Read more » Tags Antibody
The role of TCF3 as potential master regulator in blastemal Wilms tumors. Published: March, 2019 Abstract:
Wilms tumors are the most common type of pediatric kidney tumors. While the overall prognosis for patients is favorable, especially tumors that exhibit a blastemal subtype after preoperative chemotherapy have a poor prognosis. For an improved risk... Read more » Tags Antibody